These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 4625628
21. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)]. Campello C, Crevatin E. Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672 [Abstract] [Full Text] [Related]
22. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates. Melby K, Midtvedt T, Dahl O. Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179 [Abstract] [Full Text] [Related]
23. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics. Ramírez-Ronda CH, Nevárez M, Gutiérrez-Núñez JJ, Reyes Y. Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865 [No Abstract] [Full Text] [Related]
24. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. Reynolds AV, Hamilton-Miller JM, Brumfitt W. Br Med J; 1974 Sep 28; 3(5934):778-80. PubMed ID: 4213265 [Abstract] [Full Text] [Related]
25. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods. Drasar FA, Farrell W, Maskell J, Williams JD. Br Med J; 1976 Nov 27; 2(6047):1284-7. PubMed ID: 1000196 [Abstract] [Full Text] [Related]
26. Resistance to gentamicin: a growing concern. Siebert WT, Moreland NJ, Williams TW. South Med J; 1977 Mar 27; 70(3):289-92. PubMed ID: 322294 [Abstract] [Full Text] [Related]
27. Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms. Moellering RC, Wennersten C, Kunz LJ. J Infect Dis; 1976 Aug 27; 134 Suppl():S40-9. PubMed ID: 972284 [Abstract] [Full Text] [Related]
28. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Anderson EL, Gramling PK, Vestal PR, Farrar WE. Antimicrob Agents Chemother; 1975 Sep 27; 8(3):300-4. PubMed ID: 810083 [Abstract] [Full Text] [Related]
29. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance]. Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL. Pathol Biol (Paris); 1988 May 27; 36(5):435-8. PubMed ID: 3136424 [Abstract] [Full Text] [Related]
30. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Briedis DJ, Robson HG. Antimicrob Agents Chemother; 1976 Oct 27; 10(4):592-7. PubMed ID: 825032 [Abstract] [Full Text] [Related]
31. Emergence of bacteria resistant to gentamicin. Henri A, Daneau D, Klastersky J. Int J Clin Pharmacol; 1973 Nov 27; 8(3):216-21. PubMed ID: 4203920 [No Abstract] [Full Text] [Related]
37. Cross infection in a surgical ward caused by Pseudomonas aeruginosa with transferable resistance to gentamicin and tobramycin. Falkiner FR, Keane CT, Dalton M, Clancy MT, Jacoby GA. J Clin Pathol; 1977 Aug 27; 30(8):731-7. PubMed ID: 413842 [Abstract] [Full Text] [Related]
38. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates. Forgan-Smith WR, Andrew JH, McSweeney RJ. Pathology; 1976 Jul 27; 8(3):195-9. PubMed ID: 826868 [Abstract] [Full Text] [Related]
39. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin. Yourassowsky E, Schoutens E, Vanderlinden MP. Chemotherapy; 1975 Jul 27; 21(1):45-51. PubMed ID: 807457 [Abstract] [Full Text] [Related]